Abstract
Objective To assess the costs incurred by the public health services and patients as a result of tuberculosis (TB) treatment. Setting The study was conducted in a government hospital located in the northern region of Malaysia. Method Retrospective data were collected from medical records and the patients were observed until the completion of their medication. A pharmacoeconomic evaluation was applied to calculate direct and indirect costs. Main Outcome Measure Direct and indirect costs of tuberculosis treatment in a government health institution. Results Two hundred and one tuberculosis patients were included in the study. Different regimens with various durations of treatments were used. The direct medical and non-medical costs as well as indirect costs were calculated and were found to be as follows: US$61.44 for anti-tuberculosis drugs and supplies, US$28.63 for X-ray examinations, US$28.53 for laboratory tests, US$20.03 for healthcare staff time, US$4.28 for hospitalisation, US$43.20 for overhead costs, US$608.11 for transportation and meals and US$118.78 for time away from work. The cost to the patients constitutes approximately 80% of the total cost of the treatment. Conclusion The cost of treating the illness of tuberculosis per patient was US$916.4. The cost of anti-tuberculosis drugs constituted the highest proportion of the cost to the public health services (31.7%) while the cost to the patient constituted the major proportion of the total cost of the illness (79.4%).
Similar content being viewed by others
References
World Health Organization. Anti-tuberculosis drug resistance in the world. Geneva: WHO Global TB Programme; 1997.
Elsony A, Suliaman E, Shinawy A. Manual of tuberculosis control programme in Sudan, 3rd ed. Sudan: Federal Ministry of Health; 2000.
American Thoracic Society. Diagnostic standard, classification of TB in adults and children. Am. J. Respir. Care Med. 2000;161:1376–95.
World Health Organization. Towards a TB free future. Geneva: WHO/CDS/STB; 2001.
The Caribbean Epidemiology Centre. Tuberculosis manual of prevention & control procedures 1st ed. Trinidad; 1997.
World Health Organization. The economic impacts of tuberculosis. Amsterdam: Stop TB Initiative; 2000.
Wyss K, Kilima P, Lorenz N. Cost of tuberculosis for household and health care providers in Dar es Salaam, Tanzania. Trop. Med. Int. Health 2001;6:60–8.
Iseman M, Chan E. Current medical treatment for tuberculosis. BMJ 2002;320:282–6.
Lyawoo K. Tuberculosis in Malaysia: problems and prospect of treatment and control. Tuberculosis 2004;84:4–7.
Malaysia Tuberculosis Control Programme. NTB report for the year 2001. Malaysia: Ministry of Health; 2001.
Zwarenstein M, Schoeman J, Vundule C, Lombard C, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of Tuberculosis. Lancet 1998;352:1340–1343.
Jerant A, Bannon M, Rittenhouse S. Identification and management of Tuberculosis. Am. Fam. Physician 2000;61:2667–2678.
Centers for Disease Control and Prevention. Core curriculum on tuberculosis, 4th ed. Atlanta: Department of Health & Human services; 2000.
Islam M, Wakai S, Ishikawa N, Chowdhury A, Vaughan J. Cost-effectiveness of community health workers in tuberculosis control in Bangladesh. Bull. World Health Organ. 2002;80:445–50.
Sanderson P. An economic evaluation of alternative programme designs for Tuberculosis control in rural Uganda. Soc. Sci. Med. 1995;40:1203–1212.
Hurtiga A, Pande S, Porter J, Dam D. Tuberculosis treatment and private practitioners in Kathmandu Valley. J. Nap. Med. Assoc. 2000;39:163–8.
Guwatudde D, Zalwango S, Kamy M, Debanne S, Diaz M, Okwera A, Mugerwa R, King C, Whalen C. Burden of tuberculosis in Kamala, Uganda. Bull. World Health Organ. 2003;81(11):799–805.
Centers for Disease Control and Prevention. morbidity and mortality weekly report–treatment of tuberculosis. June 20, 2003/52(RR11);1–77.
Acknowledgements
The authors would like to thank all staff at the Chest Clinic of the Penang Hospital for their continuous help and their endless patience in searching for the files of tuberculosis patient throughout the data collection period. Their assistance is greatly appreciated.
Conflict of interests
We would like to declare that there is no conflict of interests in conducting this research. This study was conducted as part of the MSc research.
Author information
Authors and Affiliations
Corresponding author
Additional information
The Publisher apologises for the extreme delay in publication of this article.
Rights and permissions
About this article
Cite this article
Elamin, E.I., Ibrahim, M.I.M., Sulaiman, S.A.S. et al. Cost of illness of tuberculosis in Penang, Malaysia. Pharm World Sci 30, 281–286 (2008). https://doi.org/10.1007/s11096-007-9185-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-007-9185-0